These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 6981020

  • 1. Modulation of cell-mediated alloimmunity by BCG. I. Antagonism and potentiation of immunosuppression caused by cytarabine.
    Murahata RI, Mitchell MS.
    J Natl Cancer Inst; 1982 Sep; 69(3):607-12. PubMed ID: 6981020
    [Abstract] [Full Text] [Related]

  • 2. Modulation of cell-mediated alloimmunity by BCG. II. Induction of specific, nonadherent, non-T-killer cells by BCG and alloantigen.
    Murahata RI, Mitchell MS.
    J Natl Cancer Inst; 1982 Sep; 69(3):613-8. PubMed ID: 6810008
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis of the immunosuppressive properties of two antiviral, iodinated thymidine analogs, 5-iodo-2'-deoxyuridine and 5-iodo-5'-amino-2',5'-dideoxyuridine.
    Kan-Mitchell J, Mitchell MS, Lin TS, Prusoff WH.
    Cancer Res; 1980 Oct; 40(10):3491-4. PubMed ID: 6969112
    [Abstract] [Full Text] [Related]

  • 4. Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice.
    Berd DA, Mitchell MS.
    Cancer Res; 1976 Nov; 36(11 Pt 1):4119-24. PubMed ID: 975053
    [Abstract] [Full Text] [Related]

  • 5. T-cell-mediated antitumor immune response induced by oncofetal antigens.
    Gautam S, Deodhar SD.
    J Natl Cancer Inst; 1981 Oct; 67(4):939-45. PubMed ID: 6974275
    [Abstract] [Full Text] [Related]

  • 6. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.
    Tomazic V, Ehrke MJ, Mihich E.
    Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903
    [Abstract] [Full Text] [Related]

  • 7. Reversal by peritoneal adherent cells of tumor cell suppression of T cell-mediated immunity.
    Ting CC, Rodrigues D.
    J Immunol; 1979 Aug; 123(2):801-7. PubMed ID: 156764
    [No Abstract] [Full Text] [Related]

  • 8. Use of covalently bound cord factor analog to increase tumor immunogenicity.
    Eggers AE, Tarmin L, Ginsburg S.
    J Biol Response Mod; 1984 Aug; 3(4):413-22. PubMed ID: 6332882
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of BCG (Bacillus Calmette Guérin) sensitization on the generation of tumor specific killer T cells].
    Takeuchi M, Kimoto M, Suzuki I, Nomoto K.
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1980-6. PubMed ID: 6604499
    [Abstract] [Full Text] [Related]

  • 11. Recombinant interleukin 12 enhances cellular immune responses to vaccination only after a period of suppression.
    Kurzawa H, Wysocka M, Aruga E, Chang AE, Trinchieri G, Lee WM.
    Cancer Res; 1998 Feb 01; 58(3):491-9. PubMed ID: 9458095
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH, Griswold DE, Di Lorenzo J, Poplin EA, Calabresi P.
    Fed Proc; 1974 Aug 01; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract] [Full Text] [Related]

  • 14. Lectin potentiation of BCG-contact-mediated antitumor action.
    Poduval TB, Seshadri M, Sundaram K.
    J Natl Cancer Inst; 1980 Nov 01; 65(5):909-12. PubMed ID: 6933260
    [Abstract] [Full Text] [Related]

  • 15. Specific T cell-dependent, antigen-antibody mediated suppression of macrophages: abrogation by nonspecifically stimulated T cells.
    Rao VS, Mokyr MB, Gershon RK, Mitchell MS.
    J Immunol; 1977 Jun 01; 118(6):2117-24. PubMed ID: 325141
    [No Abstract] [Full Text] [Related]

  • 16. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
    Key ME, Hanna MG.
    J Natl Cancer Inst; 1981 Oct 01; 67(4):853-61. PubMed ID: 6944552
    [Abstract] [Full Text] [Related]

  • 17. Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: Effect of reducing or eliminating BCG load on cell-mediated immunity.
    Cross ML, Lambeth MR, Coughlan Y, Aldwell FE.
    Vaccine; 2007 Jan 26; 25(7):1297-303. PubMed ID: 17067728
    [Abstract] [Full Text] [Related]

  • 18. The binding of BCG-activated macrophages to tumor targets stimulates secretion of cytolytic factor.
    Johnson WJ, Whisnant CC, Adams DO.
    J Immunol; 1981 Nov 26; 127(5):1787-92. PubMed ID: 6795261
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer.
    Sonoda T, Sugimura K, Ikemoto S, Kawashima H, Nakatani T.
    Oncol Rep; 2007 Jun 26; 17(6):1469-74. PubMed ID: 17487406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.